申请人:Henkel Kommandigesellschaft auf Aktien
公开号:US04474807A1
公开(公告)日:1984-10-02
This invention is directed to novel antimicrobial agents. More particularly, this invention is directed to 2-(3-iodo-2-propynyloxy)-ethyl carbamates of the formula ##STR1## wherein R is hydrogen, linear or branched alkyl of from 1 to 12 carbon atoms, cycloalkyl of from 4 to 8 carbon atoms, aryl, substituted aryl, aralkyl, or arylsulfonyl; R.sup.1 and R.sup.2, which may be the same or different, each are hydrogen, linear or branched alkyl or alkenyl of from 1 to 6 carbon atoms, or cycloalkyl of from 5 to 7 carbon atoms, or R.sup.1 and R.sup.2, taken together, represent --(CH.sub.2).sub.m --, in which m is an integer of from 4 to 6; and R.sup.3, R.sup.4, R.sup.5, and R.sup.6, which may be the same or different, each represent hydrogen, alkyl of from 1 to 4 carbon atoms, or aryl, or CCl.sub.3, or R.sup.3 and R.sup.5 or R.sup.4 and R.sup.6, taken together, represent --(CH.sub.2).sub.n --, in which n is an integer of from 3 to 5, as well as a process for their preparation and their use as antimicrobial agents.
这项发明涉及新型抗微生物剂。更具体地说,这项发明涉及式中的2-(3-碘-2-丙炔氧基)-乙基氨基甲酸酯##STR1##其中R为氢、1至12个碳原子的直链或支链烷基、4至8个碳原子的环烷基、芳基、取代芳基、芳基烷基或芳基磺酰基;R.sup.1和R.sup.2,可以相同也可以不同,每个都是氢、1至6个碳原子的直链或支链烷基或烯基,或5至7个碳原子的环烷基,或R.sup.1和R.sup.2一起表示--(CH.sub.2).sub.m --,其中m是4至6的整数;以及R.sup.3、R.sup.4、R.sup.5和R.sup.6,可以相同也可以不同,每个表示氢、1至4个碳原子的烷基,或芳基,或CCl.sub.3,或R.sup.3和R.sup.5或R.sup.4和R.sup.6一起表示--(CH.sub.2).sub.n --,其中n是3至5的整数,以及它们的制备方法和作为抗微生物剂的用途。